A Novel Peptidomimetic Therapeutic for Selective Suppression of Lung Cancer Stem Cells over Non-Stem Cancer Cells

Investigators identified a highly specific peptidomimetic that selectively bound to the CSC subpopulation of lung cancer over the remaining cancer cells.